← All compounds
nootropic0 listings
Fladrafinil
Fladrafinil (CRL-40,941)
Eugeroic wakefulness compound. Alertness research.
Wakefulness researchCognitive research
/ research index
The research base
Research Maturity
★★★☆☆
3/5 — Volume of studies
Evidence Strength
★★★☆☆
3/5 — Quality of evidence
Researched for wakefulness research.
/ mechanism of action
How it works
Bisfluoro analog of adrafinil/modafinil; promotes wakefulness via dopaminergic and orexin pathways.
/ research dosing
Common research protocols
Range
100-300 mg/day
Frequency
AM, oral
Route
Oral
Cycle
Research courses
Research notes
Structurally related to modafinil. Research compound for wakefulness.
References
FOR RESEARCH USE ONLY. Doses listed are compiled from published research literature, FDA-approved drug labels, and well-documented research community practice. Not medical advice.
/ standalone use
As a solo compound
Standalone oral research compound.
/ side effects
What to know
Generally well-tolerated; see research notes.
/ timeline
Realistic expectations
Weeks
FOR RESEARCH USE ONLY. Fladrafinil is intended for laboratory research and not for human consumption.